MiNK Therapeutics INKT
NASDAQ INKT
$10.22 +0.21 (+2.14%)
As of: Nov 11, 2026 · 3:53 PM EST

MiNK Therapeutics (INKT) Net Long-Term Debt Issued (Repaid) (2024 - 2026)

Updated

MiNK Therapeutics (INKT) posted Non-Current Debt of $4.92 million for Q4 2024, up 6.8% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Net Long-Term Debt Issued (Repaid) (2024 - 2026) Analysis & Trends

Since Q1 2024, MiNK Therapeutics has reported Non-Current Debt for 4 quarters.

  • According to Business Quant data, Non-Current Debt for the three prior quarters was $4.61 million (Q3 2024), $4.41 million (Q2 2024) and $4.21 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 MiNK Therapeutics 51.02 Mn 9.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.00 Mn
Mar 31, 2024 4.21 Mn
API Access

MiNK Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=INKT&period=max&api_key=YOUR_API_KEY